Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

EastWest Bioscience Inc V.EAST.H

EastWest Bioscience Inc. is a Canada-based vertically integrated wellness company with a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets, and distributes its products to its customers in Canada, the United States and others. It owns and operates retail and manufacturing subsidiaries. Its retail subsidiary (natural health retail franchise - the Sangster's health centers) is engaged in the health and wellness industry. Its stores provide natural remedies for the prevention and treatment of disease and ailments. It has over 202 exclusively labeled products, including vitamins, mineral, herbs, proteins, natural body care and organic foods. The Company, through its subsidiary, Orchard Vale Naturals Inc., is a Health Canada licensed manufacturing facility with capabilities to encapsulate, package and label. It manufactures health supplements for B2B clients.


TSXV:EAST.H - Post by User

Post by Mhysa99on Jul 13, 2020 4:59pm
259 Views
Post# 31262430

Suspended till July 22nd

Suspended till July 22ndUNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION July 8, 2020
____________________________________
In the Matter of : : EastWest Bioscience Inc. : ORDER OF SUSPENSION : OF TRADING File No. 500-1 :
____________________________________
It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension in the trading of the securities of EastWest Bioscience Inc. (“HBOSF” or “the Company”) because of questions regarding the accuracy and adequacy of information that HBOSF is providing to the marketplace since at least May 28, 2020.
Those questions relate to statements HBOSF made about the U.S. Food and Drug Administration’s approval of the Company’s hand sanitizers in a May 28, 2020 press release issued by the Company.
HBOSF is a Canadian corporation based in Vancouver, British Columbia. The Company’s common stock is quoted on OTC Link LLC (previously “Pink Sheets”) operated by OTC Markets Group Inc., under the symbol HBOSF. As of July 6, 2020, HBOSF’s common stock had seven market makers, and was eligible for the “piggyback” exception of Rule 15c2- 11(f)(3) under the Securities Exchange Act of 1934.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed Company.
THEREFORE, IT IS ORDERED, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EDT on July 9, 2020 through 11:59 p.m. EDT on July 22, 2020. By the Commission. Vanessa A. Countryman Secretary
<< Previous
Bullboard Posts
Next >>